SCHEMBL31728602

SCHEMBL31728602

Nc1ncnc2c(-c3cccc(Cl)c3Cl)cc(N3CCCC3=O)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 1/20 0.49
▸ DGAT1 O75907 6/20 0.45
▸ FFAR1 O14842 1/20 0.38
▸ FFAR4 Q5NUL3 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HTR6 P50406 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ PTPN11 Q06124 1/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ BRDT Q58F21 1/20 0.35
▸ PDK2 Q15119 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31727998 0.83 MAP4K4 (0.49) CNR2DGAT1PTPN11MAP4K4
SCHEMBL31728568 0.81 DGAT1 (0.41) CNR2DGAT1PTPN11MAP4K4
SCHEMBL31729239 0.79 CNR2 (0.53) CNR2DGAT1ALDH1A1PTPN11
SCHEMBL31729200 0.79 DGAT1 (0.39) DGAT1PTPN11
SCHEMBL31729246 0.79 DGAT1 (0.39) CNR2DGAT1PTPN11
SCHEMBL31728894 0.77 PTPN11 (0.41) CNR2DGAT1PTPN11
SCHEMBL31729125 0.75 DGAT1 (0.38) DGAT1CYP2D6PTPN11
SCHEMBL31728779 0.74 NOTUM (0.43) DGAT1
SCHEMBL31728633 0.74 MAP4K4 (0.41) DGAT1CYP2D6MAP4K4
SCHEMBL31727873 0.74 SMN1; SMN2 (0.40) DGAT1CYP2D6SMN1; SMN2PTPN11MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback